Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery

Clinical Ophthalmology

Volumn 4, Issue 1, 2010, Pages 1505-1514

  Olson, Randall ^a   Donnenfeld, Eric ^b   Bucci Jr , Frank A ^c   Price Jr , Francis W ^d   Raizman, Michael ^e   Solomon, Kerry ^f   Devgan, Uday ^g   Trattler, William ^h   Dell, Steven ⁱ   Wallace, R Bruce ^j   Callegan, Michelle ^k   Brown, Heather ^k   McDonnell, Peter J ^l   Conway, Taryn ^m   Schiffman, Rhett M ^m   Hollander, David A ^m  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^c Bucci Laser Vision Institute   (United States)

^d PRICE VISION GROUP   (United States)

^e OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g Maloney Vision Institute   (United States)

^h Center for Excellence in Eye Care Florida   (United States)

ⁱ DELL INC   (United States)

^j Laser and Surgery Center   (United States)

^k UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m ALLERGAN INC   (United States)

more..

Author keywords

Age; Bacterial flora; Cataract surgery; Methicillin resistance; Ocular and periocular surface; Staphylococci

Indexed keywords

METICILLIN; OXACILLIN;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE STUDY; CATARACT EXTRACTION; CONJUNCTIVA; DIABETES MELLITUS; EYE; EYELID; FEMALE; GEOGRAPHIC DISTRIBUTION; GLAUCOMA; GRAM POSITIVE BACTERIUM; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHEALTH CARE WORKER; OCULAR SURFACE; PANTOEA AGGLOMERANS; PERIOCULAR DRUG ADMINISTRATION; PERIOCULAR SURFACE; PROSPECTIVE STUDY; RELATIVE; RISK FACTOR; STAPHYLOCOCCUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS CAPRAE; STAPHYLOCOCCUS CONHNII; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LENTUS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SCIURI; STAPHYLOCOCCUS WARNERI; STAPHYLOCOCCUS XYLOSUS; WORKER;

EID: 78650701468     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S14333     Document Type: Article

References (59)

1. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997;115(3): 357-361.
2. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98(5):639-649.
3. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002; 109(1):13-24.
4. Jensen MK, Fiscella RG, Moshirfar M, Mooney M. Third- and fourthgeneration fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg. 2008;34(9):1460-1467.
5. Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139(6):983-987.
6. Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology. 2007;114(4):686-691.
7. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123(5):613-620.
8. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the US Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112(8):1388-1394.
9. Lalwani GA, Flynn HW Jr, Scott IU, et al. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology. 2008; 115(3):473-476.
10. Miller DM, Vedula AS, Flynn HW Jr, et al. Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging. 2007;38(6): 446-451.
11. Dickey JB, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol. 1991;112(3): 278-282.
12. Mistlberger A, Ruckhofer J, Raithel E, et al. Anterior chamber contamination during cataract surgery with intraocular lens implantation. J Cataract Refract Surg. 1997;23(7):1064-1069.
13. Samad A, Solomon LD, Miller MA, Mendelson J. Anterior chamber contamination after uncomplicated phacoemulsification and intraocular lens implantation. Am J Ophthalmol. 1995;120(2):143-150.
14. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122(1):1-17. Erratum appears in Am J Ophthalmol. 1996;122(6):920.
15. Mollan SP, Gao A, Lockwood A, Durrani OM, Butler L. Postcataract endophthalmitis: incidence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg. 2007;33(2): 265-268. Erratum appears in J Cataract Refract Surg. 2007;33(5):759.
16. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol. 2005;123(3):341-346.
17. Deramo VA, Lai JC, Winokur J, Luchs J, Udell IJ. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureusassociated acute endophthalmitis. Am J Ophthalmol. 2008;145(3): 413-417.
18. Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961;14: 385-393.
19. Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet. 1963;1(7287):904-907.
20. National Nosocomial Infections Surveillance (NNIS) System report, data summary from Jan 1990-May 1999, issued Jun 1999. Am J Infect Control. 1999;27(6):520-532.
21. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593-598.
22. Saïd-Salim B, Mathema B, Kreiswirth BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol. 2003;24(6):451-455.
23. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Communityacquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005;5(5):275-286.
24. Asbell PA, Sahm DF, Shaw M, Draghi DC, Brown NP. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005. J Cataract Refract Surg. 2008;34(5):814-818.
25. Blomquist PH. Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:322-345.
26. Cavuoto K, Zutshi D, Karp CL, Miller D, Feuer W. Update on bacterial conjunctivitis in South Florida. Ophthalmology. 2008;115(1):51-56.
27. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007;144(2):313-315.
28. Rudd JC, Moshirfar M. Methicillin-resistant Staphylococcus aureus keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2001;27(3):471-473.
29. Shanmuganathan VA, Armstrong M, Buller A, Tullo AB. External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA). Eye. 2005;19(3):284-291.
30. Solomon R, Donnenfeld ED, Perry HD, et al. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery. Am J Ophthalmol. 2007;143(4):629-634.
31. Woodward M, Randleman JB. Bilateral methicillin-resistant Staphylococcus aureus keratitis after photorefractive keratectomy. J Cataract Refract Surg. 2007;33(2):316-319.
32. David MZ, Glikman D, Crawford SE, et al. What is communityassociated methicillin-resistant Staphylococcus aureus? J Infect Dis. 2008;197(9):1235-1243.
33. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):2976-2984.
34. Kato T, Hayasaka S. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients. Jpn J Ophthalmol. 1998;42(6): 461-465.
35. Bilen H, Ates O, Astam N, Uslu H, Akcay G, Baykal O. Conjunctival flora in patients with type 1 or type 2 diabetes mellitus. Adv Ther. 2007; 24(5):1028-1035.
36. Miño de Kaspar H, Koss MJ, He L, Blumenkranz MS, Ta CN. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol. 2005;139(4):730-733.
37. Park SH, Lim JA, Choi JS, Kim KA, Joo CK. The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea. 2009;28(1):68-72.
38. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46 Suppl 5: S344-S349.
39. Navarro MB, Huttner B, Harbarth S. Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital. Curr Opin Infect Dis. 2008;21(4):372-379.
40. Rutar T, Chambers HF, Crawford JB, et al. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006; 113(8):1455-1462.
41. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352(14):1436-1444. Erratum appears in N Eng J Med. 2005; 352(22):2362.
42. Grubeck-Loebenstein B. Changes in the aging immune system. Biologicals. 1997;25(2):205-208.
43. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273(5271):70-74.
44. Sunderkötter C, Kalden H, Luger TA. Aging and the skin immune system. Arch Dermatol. 1997;133(10):1256-1262.
45. Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:649-666.
46. Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM. Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology. 2009;116(3):425-430.
47. Kowalski RP, Romanowski EG, Mah FS, Sasaki H, Fukuda M, Gordon YJ. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model. Jpn J Ophthalmol. 2008;52(3):211-216.
48. Chi CY, Wong WW, Fung CP, Yu KW, Liu CY. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect. 2004;37(1):16-23.
49. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197(9): 1226-1234.
50. Libert M, Elkholti M, Massaut J, Karmali R, Mascart G, Cherifi S. Risk factors for methicillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian University Hospital. J Hosp Infect. 2008;68(1):17-24.
51. Trilla A, Miro JM. Identifying high risk patients for Staphylococcus aureus infections: skin and soft tissue infections. J Chemother. 1995;7 Suppl 3:37-43.
52. Warren DK, Guth RM, Coopersmith CM, Merz LR, Zack JE, Fraser VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2006;27(10):1032-1040.
53. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769-1775.
54. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985;103(9):1340-1342.
55. Miño de Kaspar H, Kreutzer TC, Aguirre-Romo I, et al. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. Am J Ophthalmol. 2008;145(1):136-142.
56. Asbell PA, Colby KA, Deng S, et al. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008;145(6):951-958.
57. Blondeau JM, Borsos S, Hesje CK. Antimicrobial eff icacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillinresistant Staphylococcus aureus. J Chemother. 2007;19(2):146-151.
58. Romanowski EG, Mah FS, Kowalski RP, Yates KA, Gordon YJ. Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis. J Ocul Pharmacol Ther. 2008;24(4):380-384.
59. Velasco D, del Mar Tomas M, Cartelle M, et al. Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus. J Antimicrob Chemother. 2005;55(3):379-382.